Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

Also called NCT06780215

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 116 participants (enrolled count) (from the registry)
Sponsor
Yihan Chen (from the registry)
Registry
  • NCT NCT06780215
Other papers using this trial's data
  • Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study Journal of the American College of Cardiology, 2026-07-14 DOI, PubMed 41778949

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06780215. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-17 (actual); primary completion 2025-09-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions
Condition
Premature Ventricular Contraction (PVC)
Intervention (Drug)
Varenicline Tartrate Tablets
Intervention (Drug)
Placebo
Lead sponsor
Yihan Chen (class: other)

Record details

Record id
cardio:ct-nct06780215
Content hash
6760ba96d1a153b5eacd70f6de5197e7d7d302c26dd1f0d7440db54a536a6982